MO
65
5
NEM
44
-2
BEN
48
-4
GM
65
-7
BWA
48
-5
VMC
60
-2
SJM
45
9
EXPD
48
-5
RIG
55
-6
MPC
44
3
CVS
52
-6
AIV
74
2
UAL
83
-2
GOOG
57
2
ZTS
47
-9
MOS
43
-5
AMG
57
2
SLG
64
-2
WDC
63
13
TEL
66
-3
MO
65
5
NEM
44
-2
BEN
48
-4
GM
65
-7
BWA
48
-5
VMC
60
-2
SJM
45
9
EXPD
48
-5
RIG
55
-6
MPC
44
3
CVS
52
-6
AIV
74
2
UAL
83
-2
GOOG
57
2
ZTS
47
-9
MOS
43
-5
AMG
57
2
SLG
64
-2
WDC
63
13
TEL
66
-3
Financhill
Back

Akari Therapeutics PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
10

AKTX
Akari Therapeutics PLC

Last Price:
1.15
Seasonality Move:
-10.36%
Sell
27

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.69
Seasonality Move:
53.66%
Sell
10
Akari Therapeutics PLC (AKTX) is a Sell

Is Akari Therapeutics PLC a Buy, Sell or Hold?

  • The current Akari Therapeutics PLC [AKTX] share price is $1.14. The Score for AKTX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • AKTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
27
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.68. The Score for ADAP is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKTX Stock Price Chart

What is Akari Therapeutics PLC's stock price today?

  • The Akari Therapeutics PLC share price today is $1.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.

AKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.37 Sell
Relative Strength Index (14 RSI): 27.32 Sell
Chaikin Money Flow: 106569 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.62 - 2.58) Sell
Bollinger Bands (100): (2.33 - 3.75) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 42.73 Sell
Chaikin Money Flow: -263450 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.66 - 0.8) Sell
Bollinger Bands (100): (0.79 - 1.21) Sell

AKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.52 Sell
20-day SMA: 2.04 Sell
50-day SMA: 2.49 Sell
200-day SMA: 2.52 Sell
8-day EMA: 1.46 Sell
20-day EMA: 1.88 Sell
50-day EMA: 2.36 Sell
200-day EMA: 2.88 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.65 Buy
20-day SMA: 0.72 Sell
50-day SMA: 0.82 Sell
200-day SMA: 1.11 Sell
8-day EMA: 0.68 Buy
20-day EMA: 0.71 Sell
50-day EMA: 0.82 Sell
200-day EMA: 0.99 Sell

Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.

Akari Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):